This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Proposal for Rational Definition, Evaluation, and Regulation

Bert J. Vermeer, MD; Barbara A. Gilchrest, MD; Dr Vermeer; Stuart L. Friedel, LLB

Arch Dermatol. 1996;132(3):337-340.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The WORD cosmeceuticals was coined nearly 10 years ago¹ by Albert M. Kligman, MD, PhD, professor emeritus of dermatology, the University of Pennsylvania, Philadelphia, a man who during his career has repeatedly crystalized issues and opportunities within dermatology. The immediate acceptance and subsequent widespread usage of this term and its variants speak to the legitimacy of a product category intermediate between cosmetics and pharmaceuticals.^2,3 Nevertheless, regulatory agencies have not yet formally recognized cosmeceuticals, despite a rapid proliferation of "cosmetic" products that have a documented and intended pharmaceutical activity and a dermatologic knowledge base that renders obsolete earlier distinctions between cosmetics and drugs. The following paragraphs review current product realities in the hope of motivating responsible persons and organizations in academe, industry, and government to confront the need for rational definitions and regulatory procedures related to skin care products in the 21st century. We include a general proposal as . . . [Full Text PDF of this Article]

Author Affiliations
Leiden, the Netherlands; Department of Dermatology Boston University School of Medicine 80 E Concord St Boston, MA 02118-2394; Department of Dermatology, University Medical Center, University of Leiden.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?